CDKN2A and oropharyngeal carcinoma: We see these differences in the evaluation of HR-SB as a risk factor and in the consideration of the discordance of the value of p16 as a surrogate parameter for a genuine HPV16 involvement in the development of oropharyngeal carcinoma (for more details, see Chapter 6.2 [49]).